Inventor · disambiguated record
Anusha Dias
Also filed as: DIAS ANUSHA · DIAS ANUSHA P
38 granted patents·18 pending applications·290 citations·filing 2002–2024
97Inventor score
Top patents by PatentIndex Score
56 records- 0198US11820977B2Methods for purification of messenger RNATRANSLATE BIO INC·Filed 2022·Granted Nov 21, 2023·3 cites·18 claims
- 0298US11692189B2Methods for purification of messenger RNATRANSLATE BIO INC·Filed 2022·Granted Jul 4, 2023·3 cites·14 claims
- 0398US9850269B2Methods for purification of messenger RNATRANSLATE BIO INC·Filed 2015·Granted Dec 26, 2017·54 cites·19 claims
- 0497US11059841B2Methods for purification of messenger RNATRANSLATE BIO INC·Filed 2018·Granted Jul 13, 2021·16 cites·18 claims
- 0597US10208295B2MRNA therapy for phenylketonuriaTRANSLATE BIO INC·Filed 2016·Granted Feb 19, 2019·22 cites·3 claims
- 0697US10155785B2Methods for purification of messenger RNATRANSLATE BIO INC·Filed 2017·Granted Dec 18, 2018·22 cites·16 claims
- 0797US9522176B2MRNA therapy for phenylketonuriaSHIRE HUMAN GENETIC THERAPIES·Filed 2014·Granted Dec 20, 2016·38 cites·12 claims
- 0896US10876104B2Methods for purification of messenger RNATRANSLATE BIO INC·Filed 2018·Granted Dec 29, 2020·6 cites·26 claims
- 0995US11920182B2Quantitative assessment for cap efficiency of messenger RNATRANSLATE BIO INC·Filed 2021·Granted Mar 5, 2024·2 cites·13 claims
- 1095US11884692B2Methods for purification of messenger RNATRANSLATE BIO INC·Filed 2022·Granted Jan 30, 2024·1 cites·16 claims
- 1194US11104934B2Quantitative assessment for cap efficiency of messenger RNATRANSLATE BIO INC·Filed 2020·Granted Aug 31, 2021·3 cites·15 claims
- 1294US10975369B2Methods for purification of messenger RNATRANSLATE BIO INC·Filed 2018·Granted Apr 13, 2021·7 cites·16 claims
- 1394US9970047B2Quantitative assessment for cap efficiency of messenger RNATRANSLATE BIO INC·Filed 2014·Granted May 15, 2018·17 cites·15 claims
- 1493US11771652B2Lipid nanoparticles for delivering mRNA vaccinesSANOFI SA·Filed 2021·Granted Oct 3, 2023·5 cites·34 claims
- 1593US11771653B2Lipid nanoparticles for delivering mRNA vaccinesSANOFI SA·Filed 2022·Granted Oct 3, 2023·5 cites·53 claims
- 1693US10808241B2Methods for purification of messenger RNATRANSLATE BIO INC·Filed 2018·Granted Oct 20, 2020·9 cites·21 claims
- 1793US9957499B2Methods for purification of messenger RNATRANSLATE BIO INC·Filed 2014·Granted May 1, 2018·38 cites·26 claims
- 1891US12239735B2Lipid nanoparticles for delivering mRNA vaccinesSANOFI SA·Filed 2023·Granted Mar 4, 2025·1 cites·45 claims
- 1990US11377642B2mRNA therapy for phenylketonuriaTRANSLATE BIO INC·Filed 2019·Granted Jul 5, 2022·2 cites·10 claims
- 2090US11365437B2Quantitative assessment for cap efficiency of messenger RNATRANSLATE BIO INC·Filed 2018·Granted Jun 21, 2022·3 cites·12 claims
- 2190US10087247B2Methods and compositions for delivering mRNA coded antibodiesTRANSLATE BIO INC·Filed 2014·Granted Oct 2, 2018·10 cites·17 claims
- 2289US12421538B2Quantitative assessment for cap efficiency of messenger RNATRANSLATE BIO INC·Filed 2024·Granted Sep 23, 2025·0 cites·21 claims
- 2389US10626439B2Quantitative assessment for cap efficiency of messenger RNATRANSLATE BIO INC·Filed 2014·Granted Apr 21, 2020·4 cites·28 claims
- 2488US11559561B2Composition and methods for treatment of primary ciliary dyskinesiaTRANSLATE BIO INC·Filed 2020·Granted Jan 24, 2023·3 cites·17 claims
- 2588US11253605B2Codon-optimized CFTR MRNATRANSLATE BIO INC·Filed 2018·Granted Feb 22, 2022·3 cites·14 claims
- 2687US11173190B2Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTRTRANSLATE BIO INC·Filed 2018·Granted Nov 16, 2021·4 cites·17 claims
- 2785US11560562B2Large-scale synthesis of messenger RNATRANSLATE BIO INC·Filed 2018·Granted Jan 24, 2023·2 cites·18 claims
- 2884US12060381B2Methods for purification of messenger RNATRANSLATE BIO INC·Filed 2022·Granted Aug 13, 2024·0 cites·33 claims
- 2983US10584165B2Methods and compositions for delivering mRNA coded antibodiesTRANSLATE BIO INC·Filed 2018·Granted Mar 10, 2020·2 cites·16 claims
- 3081US12509666B2MRNA therapy for phenylketonuriaTRANSLATE BIO INC·Filed 2022·Granted Dec 30, 2025·0 cites·21 claims
- 3178US12084711B2Quantitative assessment for cap efficiency of messenger RNATRANSLATE BIO INC·Filed 2022·Granted Sep 10, 2024·0 cites·15 claims
- 3278US2022135608A1Methods for purification of messenger rnaTRANSLATE BIO INC·Filed 2021·Application pending·0 cites
- 3377US12234446B2Methods for purification of messenger RNATRANSLATE BIO INC·Filed 2020·Granted Feb 25, 2025·0 cites·15 claims
- 3476US2025057765A1Compositions, methods and uses of messenger rnaTRANSLATE BIO INC·Filed 2024·Application pending·0 cites
- 3576US2024148651A1LIPID NANOPARTICLES FOR DELIVERING mRNA VACCINESSANOFI SA·Filed 2023·Application pending·0 cites
- 3675US7154023B2Transgenic plants with altered levels of phenolic compoundsUNIV OHIO STATE RES FOUND·Filed 2002·Granted Dec 26, 2006·5 cites·22 claims
- 3773US12410422B2Methods for purification of messenger RNATRANSLATE BIO INC·Filed 2020·Granted Sep 9, 2025·0 cites·9 claims
- 3873US12370238B2Composition and methods for treatment of primary ciliary dyskinesiaTRANSLATE BIO INC·Filed 2022·Granted Jul 29, 2025·0 cites·16 claims
- 3972US2024018514A1Large-scale synthesis of messenger rnaTRANSLATE BIO INC·Filed 2022·Application pending·0 cites
- 4071US10899830B2Methods and compositions for delivering MRNA coded antibodiesTRANSLATE BIO INC·Filed 2020·Granted Jan 26, 2021·0 cites·19 claims
- 4169US2022193247A1Novel Codon-Optimized CFTR MRNATRANSLATE BIO INC·Filed 2022·Application pending·0 cites
- 4268US11976272B2Methods for purification of messenger RNATRANSLATE BIO INC·Filed 2020·Granted May 7, 2024·0 cites·21 claims
- 4366US12076438B2Compositions, methods and uses of messenger RNATRANSLATE BIO INC·Filed 2020·Granted Sep 3, 2024·0 cites·18 claims
- 4465US2024299489A9TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF CODON-OPTIMIZED mRNA ENCODING CFTRTRANSLATE BIO INC·Filed 2021·Application pending·0 cites
- 4564US2025075201A1Screening codon-optimized nucleotide sequencesTRANSLATE BIO INC·Filed 2022·Application pending·0 cites
- 4660US2024263217A1Assay for quantitative assessment of mrna capping efficiencyTRANSLATE BIO INC·Filed 2022·Application pending·0 cites
- 4758US2023355524A1Methods and compositions for delivering mrna coded antibodiesTRANSLATE BIO INC·Filed 2023·Application pending·0 cites
- 4856US2023245721A1Generation of optimized nucleotide sequencesTRANSLATE BIO INC·Filed 2021·Application pending·0 cites
- 4954US2024219380A1Methods for measuring poly a tail lengthTRANSLATE BIO INC·Filed 2022·Application pending·0 cites
- 5054US2025268994A1Optimized Nucleotide Sequences Encoding the Extracellular Domain of Human ACE2 Protein or a Portion ThereofTRANSLATE BIO INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Anusha Dias files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →